Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eclipse Surgical Tech (ESTI) -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (85)	12/3/1999 1:59:00 AM
From: tuck	Respond to of 103

Mike, In light of your comments, that's very brave to increase your position that much. I'm thinking of rolling my calls down tomorrow should we get an extension of the dead cat bounce that finished the day. I would agree that the qtr is about done in terms of getting deals completed. Can't rely on Yahoo! hearsay -- or anyone's. I would indeed hope that management kept their lips sealed. I just wonder how Westgaard came to his conclusion. And if the sales come in the next quarter instead, that will be OK. Aside from defensive option action, I think I'll wait for the numbers to come out and the conference call. I would expect the price to stay somewhere near today's close for a number of weeks. Cheers, Tuck

To: Mike who wrote (85)	12/4/1999 8:11:00 PM
From: MJ12	Read Replies (2) \| Respond to of 103

Eclipse is still placing heart lasers in hospitals all over the country. This has not changed. Why would hospitals continue to order the equipment w/o FDA approval if it wasn't an extreme likelihood (understatement) that the approval is forthcoming. Some hospitals have the eqpt and have yet to even use it. Big money will come later with Fibre sales. This recent nosedive is an overreaction to an analyst downgrade and some insider selling. We will see $10 before the first of the year.